Impact of different visceral metastatic sites on survival in metastatic prostate cancer patients.
Gu-Shun LaiChuan-Shu ChenJason Chia-Hsien ChengJian-Ri LiCheng-Kuang YangChia-Yen LinSheng-Chun HungKun-Yuan ChiuShian-Shiang WangPublished in: PloS one (2024)
Patients with lung metastases experienced better survival outcomes in prostate cancer with only one visceral metastatic site. Liver metastases were associated with worse outcomes when there were two visceral metastatic sites combined or concomitant bone metastases. Asian patients displayed improved survival rates when compared with both Caucasian and African American patients in visceral metastatic prostate cancer.